HAIKOU, China, May 7, 2019 /PRNewswire/ -- China Pharma
Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT
listed corporation with its fully-integrated specialty
pharmaceuticals subsidiary based in China, today announced that it plans to hold
its first quarter 2019 earnings conference call on Wednesday, May 15, 2019 at 8:30 a.m. ET.
Listeners may access the call by dialing 1-866-519-4004 or
65-671-350-90 for international callers, Conference ID #
2397008. A replay of the call will be accessible through
May 23, 2019 by dialing
1-855-452-5696 or 61-281-990-299 for international callers,
Conference ID # 2397008.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical
company that develops, manufactures and markets a diversified
portfolio of products focused on conditions with a high incidence
and high mortality rates in China,
including cardiovascular, CNS, infectious, and digestive diseases.
The Company's cost-effective business model is driven by
market demand and supported by new GMP-certified product lines
covering the major dosage forms. In addition, the Company has a
broad and expanding nationwide distribution network across all
major cities and provinces in China. The Company's wholly-owned subsidiary,
Hainan Helpson Medical & Biotechnology Co., Ltd., is located in
Haikou City, Hainan Province. For more information about
China Pharma Holdings, Inc., please visit
http://www.chinapharmaholdings.com. The Company routinely posts
important information on its website.
View original
content:http://www.prnewswire.com/news-releases/cphi-to-hold-first-quarter-2019-earnings-conference-call-on-wednesday-may-15-2019-at-830-am-et-300844854.html
SOURCE China Pharma Holdings, Inc.